Emerging Toxicities
Leadership
About This Study Group
The new Emerging Toxicities Study Group will focus on acute and late toxicities that are appearing with newer classes of treatment modalities including (but not limited to) targeted therapies, antibody drug conjugates, immunotherapeutics, as well as novel radiation and surgical techniques. The group will develop initiatives, guidelines, and studies to address this new area of supportive care.
How to Join
To join a study group, you must be a MASCC member. Members can belong to up to three study groups.